Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Codoxo’s Oversubscribed Series C Led by CVS Health Ventures to Revolutionize Payment Integrity for America’s Largest Health Plans
Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Health Ventures joins the round as a new investor, with continued investment from existing investors including Sands Capital, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures (venture arm of Blue Cross and Blue Shield of Alabama), and QED Investors. This milestone brings Codoxo’s total funding raised to over $75 million.
Codoxo’s platform is rapidly being adopted by national health plans, and the latest investment will accelerate the company’s growth and its speed of innovation in its GenAI-powered payment integrity solutions. By targeting payment accuracy at Point Zero, Codoxo is transforming how payers and providers collaborate—delivering improvements that were previously unachievable with traditional methods.
The funding comes at a pivotal time as healthcare payers face mounting pressure to reduce costs while improving provider relationships. Codoxo’s Point Zero approach represents a fundamental shift in payment integrity, identifying and preventing payment errors at the earliest possible moment —before they occur —rather than detecting them after the fact.
“This funding highlights the support for Codoxo’s differentiated approach and the importance of closing gaps in payment integrity programs across national health plans,” said Musheer Ahmed, Ph.D., Founder and CEO at Codoxo…
Full release here, originally announced December 17th, 2025.
Mass General Brigham Announces New AI Company to Accelerate Clinical Trial Screening and Patient Recruitment
Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly outperformed manual screening for determining a patient’s eligibility and enrolling them in a clinical trial.
The tool, RECTIFIER (RAG-Enabled Clinical Trial Infrastructure for Inclusion Exclusion Review), was first developed and studied by researchers at Mass General Brigham’s Accelerator for Clinical Transformation. Since the publications of a proof-of-concept study in June 2024 and a randomized-controlled blinded trial in February 2025, RECTIFIER’s use has continued to expand across the healthcare system, with more than 20 active and onboarding use cases in research and clinical operations, including in cardiology, oncology, gastroenterology, neurology, pathology, and psychiatry.
RECTIFIER represents the first new company spun out by Mass General Brigham involving a Retrieval-Augmented Generation (RAG) AI application developed by researchers within the health system.
Through AIwithCare and its AIwithCare Studio platform, the researchers plan to scale this capability to other healthcare systems, hospitals, and clinics seeking to match their patient populations with relevant clinical trials and support medical and operational applications with improved analytics.
“Building tools that fit smoothly into clinical trial workflows requires cross-functional teams with expertise in clinical practice and with technical aptitude. That includes change management, software development, information security, and product and program management,” said Jane Moran, Chief Information and Data Officer at Mass General Brigham…
Full release here, originally announced December 12th, 2025.
No comments:
Post a Comment